Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Item
http://www.wikidata.org/entity/Q37624673
Challenges of antibacterial discoveryThe crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms.Peptide deformylase inhibitors as potent antimycobacterial agents.New advances in antibiotic development and discovery.Therapeutic potential of peptide deformylase inhibitors.Zinc is the metal cofactor of Borrelia burgdorferi peptide deformylase.Drug forecast - the peptide deformylase inhibitors as antibacterial agents.Investigational treatments for postoperative surgical site infections.Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).Combating multidrug-resistant Gram-negative bacterial infections.Novel targets for antibiotics in Staphylococcus aureus.Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.
P2860

Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Item
http://www.wikidata.org/entity/Q37624673
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@en
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@nl
type
label
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@en
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@nl
prefLabel
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@en
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.48.12.4835-4842.2004
P407
P433
P478
P577
P698
P932